These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29150966)

  • 1. Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study.
    Goet JC; Hansen BE; Tieleman M; van Hoek B; van den Berg AP; Polak WG; Dubbeld J; Porte RJ; Konijn-Janssen C; de Man RA; Metselaar HJ; de Vries AC
    Transpl Int; 2018 Jun; 31(6):590-599. PubMed ID: 29150966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era.
    Klose J; Klose MA; Metz C; Lehner F; Manns MP; Klempnauer J; Hoppe N; Schrem H; Kaltenborn A
    Langenbecks Arch Surg; 2014 Dec; 399(8):1021-9. PubMed ID: 24888532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
    J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.
    Brandsaeter B; Broomé U; Isoniemi H; Friman S; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Olsson R; Olausson M; Kirkegaard P; Bjøro K
    Liver Transpl; 2003 Sep; 9(9):961-9. PubMed ID: 12942458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.
    Goldberg D; French B; Thomasson A; Reddy KR; Halpern SD
    Liver Transpl; 2011 Nov; 17(11):1355-63. PubMed ID: 21837735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - Impact of changes in allocation policy.
    Staufer K; Kivaranovic D; Rasoul-Rockenschaub S; Soliman T; Trauner M; Berlakovich G
    HPB (Oxford); 2018 Oct; 20(10):916-924. PubMed ID: 29937419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in living donor liver transplantation for primary sclerosing cholangitis.
    Goldberg DS; French B; Thomasson A; Reddy KR; Halpern SD
    Transplantation; 2011 May; 91(10):1148-52. PubMed ID: 21544035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donation after cardiac death liver transplantation in primary sclerosing cholangitis: proceed with caution.
    Sundaram V; Choi G; Jeon CY; Ayoub WS; Nissen NN; Klein AS; Tran TT
    Transplantation; 2015 May; 99(5):973-8. PubMed ID: 25340598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.
    Henson JB; Patel YA; King LY; Zheng J; Chow SC; Muir AJ
    Liver Transpl; 2017 Jun; 23(6):769-780. PubMed ID: 28027592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis.
    Goldberg DS; Camp A; Martinez-Camacho A; Forman L; Fortune B; Reddy KR
    Liver Transpl; 2013 Mar; 19(3):250-8. PubMed ID: 23213009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation.
    Singal AK; Fang X; Kaif M; Hasanin M; Mcguire BM; Kuo YF; Wiesner RH
    Transpl Int; 2017 May; 30(5):454-462. PubMed ID: 27754570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.
    Henson JB; Patel YA; Wilder JM; Zheng J; Chow SC; King LY; Muir AJ
    Dig Dis Sci; 2017 Nov; 62(11):3200-3209. PubMed ID: 28391417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
    Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
    Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.
    Fosby B; Melum E; Bjøro K; Bennet W; Rasmussen A; Andersen IM; Castedal M; Olausson M; Wibeck C; Gotlieb M; Gjertsen H; Toivonen L; Foss S; Makisalo H; Nordin A; Sanengen T; Bergquist A; Larsson ME; Soderdahl G; Nowak G; Boberg KM; Isoniemi H; Keiding S; Foss A; Line PD; Friman S; Schrumpf E; Ericzon BG; Höckerstedt K; Karlsen TH
    Scand J Gastroenterol; 2015 Jun; 50(6):797-808. PubMed ID: 25959101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitis.
    Onofrio F; Zheng K; Xu C; Chen S; Xu W; Vyas M; Bingham K; Patel K; Lilly L; Cattral M; Selzner N; Jaeckel E; Tsien C; Gulamhusein A; Hirschfield GM; Bhat M
    Hepatol Commun; 2023 Aug; 7(8):. PubMed ID: 37534935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis.
    Martin EF; Levy C
    Semin Liver Dis; 2017 Nov; 37(4):305-313. PubMed ID: 29272893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.
    Brandsaeter B; Schrumpf E; Bentdal O; Brabrand K; Smith HJ; Abildgaard A; Clausen OP; Bjoro K
    Liver Transpl; 2005 Nov; 11(11):1361-9. PubMed ID: 16184522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.